Page last updated: 2024-12-05

ethylene bromohydrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethylene bromohydrin: RN given refers to 2-bromo cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10898
CHEMBL ID468583
SCHEMBL ID7949
MeSH IDM0084863

Synonyms (67)

Synonym
2-bromo-ethanol
wln: q2e
nsc-2869
2-hydroxyethyl bromide
2-bromoethanol
glycol bromohydrin
1-bromo-2-ethanol
540-51-2
ethanol, 2-bromo-
ethylene bromohydrin
nsc2869
bromoethanol
BRJ ,
inchi=1/c2h5bro/c3-1-2-4/h4h,1-2h
NCGC00091063-01
2-bromo-1-ethanol
2-bromoethyl alcohol
nsc 2869
ethylenebromohydrin
einecs 208-748-1
ai3-15350
brn 0878140
ccris 3862
2-bromoethanol, analytical standard
2-bromoethanol, 95%
B0590
AKOS000118753
CHEMBL468583
NCGC00091063-02
29155-34-8
2-bromoethan-1-ol
NCGC00258589-01
dtxcid20200
tox21_201036
cas-540-51-2
dtxsid8020200 ,
2-bromanylethanol
A829928
unii-z33995s34r
z33995s34r ,
4-01-00-01385 (beilstein handbook reference)
FT-0611552
ethylene bromohydrin [mi]
.beta.-bromoethyl alcohol
BP-21193
RP10172
SCHEMBL7949
1-bromoethan-2-ol
glycol bromohydrine
ethylenebromohydrine
2bromoethanol
br(ch2)2oh
brch2ch2oh
2-bromo ethanol
2- bromo ethanol
2-bromethanol
W-105680
ch2brch2oh(trans)
STR01207
F2190-0181
mfcd00002827
2-bromoethanol, purum, >=95.0% (gc)
BCP24052
Q26841231
STL193987
AMY39504
EN300-21258

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These results suggest that dibromoalkane-induced cell lysis is due to lipid peroxidation as well as cytochrome P450-dependent formation of toxic bromoaldehydic metabolites which can bind with cellular macromolecules."( Molecular mechanisms of dibromoalkane cytotoxicity in isolated rat hepatocytes.
Khan, S; O'Brien, PJ; Sood, C, 1993
)
0.29
" Bromoacetaldehyde was more toxic (EC(50)60 mu M, 2 hr) and bromoacetic acid was less toxic (EC(50)150 mu M, 2 hr)."( The involvement of cytochrome P4502E1 in 2-bromoethanol-induced hepatocyte cytotoxicity.
Khan, S; O'Brien, PJ; Sood, C, 1996
)
0.29

Dosage Studied

ExcerptRelevanceReference
" The mean total dosage per mouse was 2110."( [Carcinogenic activity of ethylene oxide and its reaction products 2-chloroethanol, 2-bromoethanol, ethylene glycol and diethylene glycol. III. Research on ethylene glycol and diethylene glycol for carcinogenic effects].
Dunkelberg, H, 1987
)
0.27
"3 mg, single dosage per mouse) and 2-bromoethanol in 2 dosages (1."( [Carcinogenic activity of ethylene oxide and its reaction products 2-chlorethanol, 2-bromoethanol, ethylene glycol and diethylene glycol. II. Testing of 2-chlorethanol and 2-bromoethanol for carcinogenic activity].
Dunkelberg, H, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency1.58490.010039.53711,122.0200AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency34.94270.000627.21521,122.0200AID651741; AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID384212Mutagenic activity in Salmonella Typhimurium TA100 assessed as logarithm of his+ revertant number increasing activity by amens test2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (HAA) mutagenicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (50.00)18.7374
1990's3 (12.50)18.2507
2000's4 (16.67)29.6817
2010's4 (16.67)24.3611
2020's1 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.89 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]